Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease

Yi Chang Cheng, Wei Wen Kuo, Chieh Hsi Wu, Wen Tong Shu, Chia Hua Kuo, Jin Ming Hwang, Hsi Hsien Hsu, Li Ming Chen, Chih Yang Huang, Shin Da Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim: The study aimed to investigate whether imbalanced iron status in patients with haemodialysis coexisted with abnormal lipid profile, higher inflammatory status and altered growth hormone-insulin-like growth factor (GH-IGF)-I axis and to compare these biochemical markers with patients with ischaemic heart disease. Methods: Serum samples for biochemical and immunological analyses were collected from 74 normal subjects, 138 patients with ischaemic heart disease (IHD) and 115 patients on haemodialysis (HD). Results: Compared with normal subjects, lower serum iron, lower total iron-binding capacity (TIBC) and higher ferritin in HD patients coexisted with decreases in high-density lipoprotein cholesterol and total bilirubin as well as increases in lactate dehydrogenase (LDH), interleukin (IL)-6, C-reactive protein (CRP) and IL-10. Decreased IGF-I and increased GH were found in HD patients whereas unchanged GH-IGF axis were found in IHD patients. Compared with IHD, much higher ferritin, lower TIBC, lower bilirubin and higher LDH levels were found in HD patients. Conclusion: Imbalanced iron status in patients on HD coexisted with abnormal lipid profiles, increased anaerobic activity and higher inflammatory status, which suggests that imbalanced iron status in HD patients may play a deleterious role in cardiovascular pathophysiology. Altered GH-IGF axis found in HD patients was more obvious than in IHD patients. This may imply that the GH-IGF axis system is modulated or adapted by HD.

Original languageEnglish
Pages (from-to)65-69
Number of pages5
JournalNephrology
Volume14
Issue number1
DOIs
Publication statusPublished - Feb 2009
Externally publishedYes

Fingerprint

Myocardial Ischemia
Renal Dialysis
Iron
Growth Hormone
Somatomedins
Ferritins
Insulin-Like Growth Factor I
L-Lactate Dehydrogenase
Bilirubin
Lipids
Serum
Interleukin-10
C-Reactive Protein
HDL Cholesterol
Interleukin-6
Biomarkers

Keywords

  • Cardiac markers
  • Chronic renal failure
  • Coronary artery disease
  • Proinflammatory
  • Serum iron

ASJC Scopus subject areas

  • Nephrology

Cite this

Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease. / Cheng, Yi Chang; Kuo, Wei Wen; Wu, Chieh Hsi; Shu, Wen Tong; Kuo, Chia Hua; Hwang, Jin Ming; Hsu, Hsi Hsien; Chen, Li Ming; Huang, Chih Yang; Lee, Shin Da.

In: Nephrology, Vol. 14, No. 1, 02.2009, p. 65-69.

Research output: Contribution to journalArticle

Cheng, YC, Kuo, WW, Wu, CH, Shu, WT, Kuo, CH, Hwang, JM, Hsu, HH, Chen, LM, Huang, CY & Lee, SD 2009, 'Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease', Nephrology, vol. 14, no. 1, pp. 65-69. https://doi.org/10.1111/j.1440-1797.2008.01004.x
Cheng, Yi Chang ; Kuo, Wei Wen ; Wu, Chieh Hsi ; Shu, Wen Tong ; Kuo, Chia Hua ; Hwang, Jin Ming ; Hsu, Hsi Hsien ; Chen, Li Ming ; Huang, Chih Yang ; Lee, Shin Da. / Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease. In: Nephrology. 2009 ; Vol. 14, No. 1. pp. 65-69.
@article{76839f590a8f4e0f82890592f8b18da8,
title = "Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease",
abstract = "Aim: The study aimed to investigate whether imbalanced iron status in patients with haemodialysis coexisted with abnormal lipid profile, higher inflammatory status and altered growth hormone-insulin-like growth factor (GH-IGF)-I axis and to compare these biochemical markers with patients with ischaemic heart disease. Methods: Serum samples for biochemical and immunological analyses were collected from 74 normal subjects, 138 patients with ischaemic heart disease (IHD) and 115 patients on haemodialysis (HD). Results: Compared with normal subjects, lower serum iron, lower total iron-binding capacity (TIBC) and higher ferritin in HD patients coexisted with decreases in high-density lipoprotein cholesterol and total bilirubin as well as increases in lactate dehydrogenase (LDH), interleukin (IL)-6, C-reactive protein (CRP) and IL-10. Decreased IGF-I and increased GH were found in HD patients whereas unchanged GH-IGF axis were found in IHD patients. Compared with IHD, much higher ferritin, lower TIBC, lower bilirubin and higher LDH levels were found in HD patients. Conclusion: Imbalanced iron status in patients on HD coexisted with abnormal lipid profiles, increased anaerobic activity and higher inflammatory status, which suggests that imbalanced iron status in HD patients may play a deleterious role in cardiovascular pathophysiology. Altered GH-IGF axis found in HD patients was more obvious than in IHD patients. This may imply that the GH-IGF axis system is modulated or adapted by HD.",
keywords = "Cardiac markers, Chronic renal failure, Coronary artery disease, Proinflammatory, Serum iron",
author = "Cheng, {Yi Chang} and Kuo, {Wei Wen} and Wu, {Chieh Hsi} and Shu, {Wen Tong} and Kuo, {Chia Hua} and Hwang, {Jin Ming} and Hsu, {Hsi Hsien} and Chen, {Li Ming} and Huang, {Chih Yang} and Lee, {Shin Da}",
year = "2009",
month = "2",
doi = "10.1111/j.1440-1797.2008.01004.x",
language = "English",
volume = "14",
pages = "65--69",
journal = "Nephrology",
issn = "1320-5358",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Iron status and cardiovascular risk factors in patients with haemodialysis versus patients with ischaemic heart disease

AU - Cheng, Yi Chang

AU - Kuo, Wei Wen

AU - Wu, Chieh Hsi

AU - Shu, Wen Tong

AU - Kuo, Chia Hua

AU - Hwang, Jin Ming

AU - Hsu, Hsi Hsien

AU - Chen, Li Ming

AU - Huang, Chih Yang

AU - Lee, Shin Da

PY - 2009/2

Y1 - 2009/2

N2 - Aim: The study aimed to investigate whether imbalanced iron status in patients with haemodialysis coexisted with abnormal lipid profile, higher inflammatory status and altered growth hormone-insulin-like growth factor (GH-IGF)-I axis and to compare these biochemical markers with patients with ischaemic heart disease. Methods: Serum samples for biochemical and immunological analyses were collected from 74 normal subjects, 138 patients with ischaemic heart disease (IHD) and 115 patients on haemodialysis (HD). Results: Compared with normal subjects, lower serum iron, lower total iron-binding capacity (TIBC) and higher ferritin in HD patients coexisted with decreases in high-density lipoprotein cholesterol and total bilirubin as well as increases in lactate dehydrogenase (LDH), interleukin (IL)-6, C-reactive protein (CRP) and IL-10. Decreased IGF-I and increased GH were found in HD patients whereas unchanged GH-IGF axis were found in IHD patients. Compared with IHD, much higher ferritin, lower TIBC, lower bilirubin and higher LDH levels were found in HD patients. Conclusion: Imbalanced iron status in patients on HD coexisted with abnormal lipid profiles, increased anaerobic activity and higher inflammatory status, which suggests that imbalanced iron status in HD patients may play a deleterious role in cardiovascular pathophysiology. Altered GH-IGF axis found in HD patients was more obvious than in IHD patients. This may imply that the GH-IGF axis system is modulated or adapted by HD.

AB - Aim: The study aimed to investigate whether imbalanced iron status in patients with haemodialysis coexisted with abnormal lipid profile, higher inflammatory status and altered growth hormone-insulin-like growth factor (GH-IGF)-I axis and to compare these biochemical markers with patients with ischaemic heart disease. Methods: Serum samples for biochemical and immunological analyses were collected from 74 normal subjects, 138 patients with ischaemic heart disease (IHD) and 115 patients on haemodialysis (HD). Results: Compared with normal subjects, lower serum iron, lower total iron-binding capacity (TIBC) and higher ferritin in HD patients coexisted with decreases in high-density lipoprotein cholesterol and total bilirubin as well as increases in lactate dehydrogenase (LDH), interleukin (IL)-6, C-reactive protein (CRP) and IL-10. Decreased IGF-I and increased GH were found in HD patients whereas unchanged GH-IGF axis were found in IHD patients. Compared with IHD, much higher ferritin, lower TIBC, lower bilirubin and higher LDH levels were found in HD patients. Conclusion: Imbalanced iron status in patients on HD coexisted with abnormal lipid profiles, increased anaerobic activity and higher inflammatory status, which suggests that imbalanced iron status in HD patients may play a deleterious role in cardiovascular pathophysiology. Altered GH-IGF axis found in HD patients was more obvious than in IHD patients. This may imply that the GH-IGF axis system is modulated or adapted by HD.

KW - Cardiac markers

KW - Chronic renal failure

KW - Coronary artery disease

KW - Proinflammatory

KW - Serum iron

UR - http://www.scopus.com/inward/record.url?scp=63149130185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63149130185&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1797.2008.01004.x

DO - 10.1111/j.1440-1797.2008.01004.x

M3 - Article

VL - 14

SP - 65

EP - 69

JO - Nephrology

JF - Nephrology

SN - 1320-5358

IS - 1

ER -